Glycemic variability: adverse clinical outcomes and how to improve it?

Glycemic variability (GV), defined as an integral component of glucose homoeostasis, is emerging as an important metric to consider when assessing glycemic control in clinical practice. Although it remains yet no consensus, accumulating evidence has suggested that GV, representing either short-term...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Zheng, Sun, Bao, Huang, Shiqiong, Zhu, Chunsheng, Bian, Meng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335439/
https://www.ncbi.nlm.nih.gov/pubmed/32622354
http://dx.doi.org/10.1186/s12933-020-01085-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335439/
https://www.ncbi.nlm.nih.gov/pubmed/32622354
http://dx.doi.org/10.1186/s12933-020-01085-6

Ejemplares similares